Healthcare and tech focus Riverside Partners specializes in growth‑oriented healthcare and technology companies in the middle market, presenting a clear target for sales conversations around scalable software, compliance, revenue cycle optimization, and clinical/operational efficiency solutions.

Founder‑friendly investor Recognition as founder‑friendly and hands‑on operators suggests open collaboration with portfolio leadership; opportunities exist to offer strategic consulting, go‑to‑market acceleration, and operating improvements that align with their value‑creation approach.

Portfolio growth signals Recent acquisitions and funding activity (HST acquisition by UnisLink, Loftware growth, and investments in revenue cycle firms) indicate a continuing appetite for add‑on acquisitions and growth platforms; potential fit for integration‑platforms, analytics, and scalable services.

North American focus Target companies operate across North America with EBITDA in the mid‑single to mid‑teens; sales initiatives can emphasize regulatory readiness, cross‑border scalability (US/Canada), and financing readiness to support expansion.

Fund size and scope Riverside is deploying Riverside Fund VI with a size and mandate that prioritizes value creation through operating expertise; prospective vendors and service providers should position offerings that demonstrate measurable ROI, implementation speed, and portfolio‑level impact.